Personal Information
Organization / Workplace
Hyderabad, Sindh Pakistan
Occupation
Student
Industry
Education
About
My name is Gul Muneer. Currently, I am pursuing doctorate degree.
Tags
nanopots
nanodroplet processing in one pot for trace sample
microproteomics
proteomics
microfluidics
nanodroplet
cptac
clinical proteomic tumor analysis consortium
therapeutic opportunities
colon cancer
proteogenomics
cross tumor models
prognostic utility
therapeutic ultility
predicting patient survival
clinically relevant genes
clinically actionable genes
somatic alterations
random survival forest
cox
lasso
prognosis
prognostics
patient survival
survival data
tumor types
cancer genomic and proteomic
clinical utility
myeloid cells
bone-resident cells.
cancer-promoting
siglecf
neutrophils
lung tumors
osteoblasts
cobra approach
epitope approach
hemagglutinin
influenza virus
universal influenza vaccine
omalizumab
ige-r419n-fc3–4
ige-fc
ige
cd23
basophils
allergy
proliferation & differentiation
metabolism
t cell memory
lc-ms/ms
mass spectrometry
quantitative proteomics
anti-tumor
survival
t cell
l-arginine
melanoma vesicles
vesicles
subcapsular sinus
lymph nodes
tumor-derived extracellular vesicles (tevs)
tumor-draining lymph nodes (tdlns)
10.1126/science.aaf1328
melanoma
scs macrophages
niacinamide 0r nicotinamide
niacin
vitamin b3
glycogenolysis
glycogen breakdown
See more
Presentations
(11)Likes
(5)Glycogenolysis Basic
Sana Arbab
•
9 years ago
world production of edible mushrooms and edible mushrooms of pakistan
Jannat Iftikhar
•
9 years ago
Plasma/Cell Membrane
Gul Muneer
•
10 years ago
Vitamin B3 Niacin
Gul Muneer
•
10 years ago
Glycogenolysis
Gul Muneer
•
10 years ago
Personal Information
Organization / Workplace
Hyderabad, Sindh Pakistan
Occupation
Student
Industry
Education
About
My name is Gul Muneer. Currently, I am pursuing doctorate degree.
Tags
nanopots
nanodroplet processing in one pot for trace sample
microproteomics
proteomics
microfluidics
nanodroplet
cptac
clinical proteomic tumor analysis consortium
therapeutic opportunities
colon cancer
proteogenomics
cross tumor models
prognostic utility
therapeutic ultility
predicting patient survival
clinically relevant genes
clinically actionable genes
somatic alterations
random survival forest
cox
lasso
prognosis
prognostics
patient survival
survival data
tumor types
cancer genomic and proteomic
clinical utility
myeloid cells
bone-resident cells.
cancer-promoting
siglecf
neutrophils
lung tumors
osteoblasts
cobra approach
epitope approach
hemagglutinin
influenza virus
universal influenza vaccine
omalizumab
ige-r419n-fc3–4
ige-fc
ige
cd23
basophils
allergy
proliferation & differentiation
metabolism
t cell memory
lc-ms/ms
mass spectrometry
quantitative proteomics
anti-tumor
survival
t cell
l-arginine
melanoma vesicles
vesicles
subcapsular sinus
lymph nodes
tumor-derived extracellular vesicles (tevs)
tumor-draining lymph nodes (tdlns)
10.1126/science.aaf1328
melanoma
scs macrophages
niacinamide 0r nicotinamide
niacin
vitamin b3
glycogenolysis
glycogen breakdown
See more